A frequent finding in the majority of conventional clear cell carcinomas is a mutation in the von Hippel-Lindau (VHL) suppressor gene (Ma et al, 2001), the protein product of this gene is required for degradation of hypoxia-inducible factor 1α (HIF-1α). This evidence concerns the gene VHL and clear cell adenocarcinoma.